https://doi.org/10.4081/jbr.2022.10772

A concept for causality assessment and causal inference of adverse events cases

Vol. 95 No. 2 (2022)
Submitted: August 3, 2022
Accepted: October 19, 2022
Published: November 2, 2022
Chemical and drug-induced liver injury, pharmacovigilance, RUCAM system, signal Detection, WHO-UMC causality assessment system
Abstract Views: 817
PDF: 332
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Ahmed Al-Imam
ahmed.mohammed@comed.uobaghdad.edu.iq
https://orcid.org/0000-0003-1846-9424
Department of Anatomy and Cellular Biology, College of Medicine, University of Baghdad, Baghdad, Iraq; Department of Computer Science and Statistics, Doctoral School, Poznan University of Medical Sciences, Poznan, Poland; Alumni Ambassador, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Ahmed Sami
College of Pharmacy, Al-Mustansiriya University, Baghdad, Iraq; Baghdad Teaching Hospital, Baghdad Medical City Teaching Complex, Baghdad, Iraq.
Samantha Lane
Drug Safety Research Unit, Southampton, United Kingdom.
Manal Younus
Iraqi Pharmacovigilance Centre, Ministry of Health, Baghdad, Iraq; International Society of Pharmacovigilance, Middle East Chapter, London, United Kingdom.

Dear Editor,

 

Causality assessment of adverse drug events is essential in pharmacovigilance to assess the relationship between the medicine and the event.1,2 Regulatory authorities recommend using standardized methods for causality assessment.3,4 The World Health Organization-Uppsala Monitoring Center (WHO-UMC) system offers generalized criteria for establishing causal relationships.3 In contrast, the Roussel Uclaf Causality Assessment Method (RUCAM) provides a specialized system to assess Drug-Induced Liver Injury (DILI) cases. We systematically reviewed the literature and verified that these systems are among the best tools currently available for signal detection and causality assessment. [...]

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255-9.
Al-Imam A, Motyka MA, Witulska Z, et al. Spatiotemporal mapping of online interest in cannabis and popular psychedelics before and during the COVID-19 pandemic in Poland. Int J Environ Res Public Health 2022;19:6619.
The World Health Organization. The use of the WHO-UMC system for standardised case causality assessment [Internet]. Who.int. 2013.Accessed 1 July 2022. Available from: https://www.who.int/publications/m/item/WHO-causality-assessment
LiverTox: Clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Roussel Uclaf Causality Assessment Method (RUCAM) in Drug Induced Liver Injury. Updated 2019 May 4. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548272/
Drug-induced liver injury (DILI): Current status and future directions for drug development and the post-market setting. A consensus by a CIOMS Working Group. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS), 2020.
Kassid OM, Odhaib SA, Altemimi MT. Flutamide-induced hepatotoxicity: A case report. J Biol Res 2022; ahead of print. doi: 10.4081/jbr.2022.10371
U.S. Food and Drug Administration. DILIrank [Internet]. Liver Toxicity Knowledge Base (LTKB). 2022. Accessed 1 July 2022. Available from: https://www.fda.gov/science-research/bioinformatics-tools/liver-toxicity-knowledge-base-ltkb
LiverTox: Clinical and research information on drug-induced liver injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. PMID: 31643176.
Larasati A, DeYong C, Slevitch L. Comparing neural network and ordinal logistic regression to analyze attitude responses. Serv Sci 2011;3:304-12.
Uppsala Monitoring Centre. VigiFlow [Internet]. Vigiflow.who-umc.org. 2022. Accessed 29 September 2022. Available from: https://vigiflow.who-umc.org/
Uppsala Monitoring Centre. VigiLyze [Internet]. Vigiflow.who-umc.org. 2022. Accessed 29 September 2022. Available from: https://vigilyze.who-umc.org/
Abd AK, Kadhim DJ, Younus MM. Assessment of causality, severity and seriousness of adverse event following immunization in Iraq: A retrospective study based on Iraqi Pharmacovigilance Database. Iraqi J Pharm Sci 2019;28:142-50.
Al-Imam A. Optimizing Linear Models via Sinusoidal Transformation for Boosted Machine Learning in Medicine. J Fac Med Baghdad 2019;61:128-36.

How to Cite

Al-Imam, A., Sami, A., Lane, S., & Younus, M. (2022). A concept for causality assessment and causal inference of adverse events cases. Journal of Biological Research - Bollettino Della Società Italiana Di Biologia Sperimentale, 95(2). https://doi.org/10.4081/jbr.2022.10772
Copyright (c) 2022 the Authors Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.